GNU Free Documentation License . .

( « »)
: ,
AMI scheme.png
(2) ( )
-10 I21.21.-I22.22.
-9 410410
DiseasesDB 8664 8664
MedlinePlus 000195 000195
eMedicine med/1567  emerg/327emerg/327 ped/2520ped/2520 med/1567  emerg/327emerg/327 ped/2520ped/2520

́ ́  , , .   .[1]

[]

:

  1. (0-18 )
  2. ( 2 )
  3. ( 10 )
  4. ( 10 4-8 )
  5. ( 4-8 6 )

:

:

  1. (), Q-
  2. , Q-
  • .
    1. (, , , ).
    2. .
    3. ().
    4. .
    5. : -, - .

:

  3. ( 1 , 72 8 )
  4. ( . . ., 28 )

, , , (2007)[2]:

  • ( 1), , / , .
  • ( 2), , -, , , , , , - .
  • ( 3), , ST , / -, .
  • - ( 4).
  • , ( 4), .
  • - ( 5).

, . , « » « » ( , ) : , , , , , , .

[]

( ). ( ):

  1. (, ) 93-98 %
  2. ( )
  3. ( , . .)

( )

[]

[]

:

  2. ()

. , , . 4 7 . . 1-2 . 1-2 .

[]

  ( ). . , , , , .[6] , .

15 ( 1 ) , , . .

20-30 % . , .

. . .

, , , .

[]

. . :

  •   , , , , . .
  •   . .
  • , , , , .
  • . , ().
  •   , , .
  • , , , , .

[]

: - = , - = .
.
  1. :
    3. (MB-, , 1, [7])
  2. :

[]

:

:

[]

, ( , , ). .

- . .

[] ,

, [11] (0,5 ) (0,4  ). 5 , . 5 , . , . 10  10 0,9 % . 2-5  ( 2-5 ) . 2-5  5-15 .

ST .[12]

  (0,05-0,1 ) (2,5-10  ). .

( <90 %), ( ) 2-5 /. .

, 2009 2010 , , .[13][14]

, , ( ) (, 2,5-10 ). .

[]

, , 150300 .[15][16] - , . , , 250500 . 75-150 /. 300  75 /[17][18]. , ST[19].

[]

48 . 60 / ( 4000 ), 13 // ( 100 /) , , 1,5-2 3, 6, 12, 24 .

(), 1 / 2 5-7 . 15 / 30  . 2 /   100 . : .

2,5  1 . .

[]

ST . , , . 12 . 1,5 100 0,9 % 30-60 . 100200 : 15  , 0,75 / 30 ( 50 ) 0,5 / 60 ( 35 ). , .

[] -

, . - .

[]

, , . , , , , .

, (. Colony-stimulating factor) , .[20]

, Cochrane Collaboration 2012 , , .[21]

[]

[]

, , .

[]


  . , .


Myocardial infarction (.)
, .

[]

  1. Bupa. Heart Attack, 2011
  2. Universal Definition of Myocardial Infarction. Circulation.2007; 116: 2634-2653 Published online before print October 19, 2007,doi: 10.1161/CIRCULATIONAHA.107.187397
  3. U.S. Department of Health and Human Services. Reducing the Health Consequences of Smoking: 25 Years of Progress. A Report of the Surgeon General. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1989 [accessed 2009 May 5].
  4. Peters A, von Klot S, Heier M, Trentinaglia I, Hormann A, Wichmann HE, et al. 2004. Exposure to traffic and the onset of myocardial infarction. N Engl J Med 351:17211730
  5. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, Tanomsup S, Wangai P Jr, Razak F, Sharma AM, Anand SS; INTERHEART Study Investigators. (2005). «Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study». Lancet 366 (9497): 16409. DOI:10.1016/S0140-6736(05)67663-5. PMID 16271645.
  6. Mallinson, T (2010). «Myocardial Infarction». Focus on First Aid (15): 15. 2010-06-08.
  8. McMurray JJ, Pfeffer MA (2005). «Heart failure». Lancet 365 (9474): 187789. DOI:10.1016/S0140-6736(05)66621-4. PMID 15924986.
  9. Podrid Philip J. Cardiac Arrhythmia: Mechanisms, Diagnosis, and Management.  Lippincott Williams & Wilkins, 2001.  ISBN 0781724864
  10. Yip HK, Wu CJ, Chang HW, Wang CP, Cheng CI, Chua S, Chen MC. (2003). «Cardiac rupture complicating acute myocardial infarction in the direct percutaneous coronary intervention reperfusion era» (PDF). Chest 124 (2): 56571. DOI:10.1378/chest.124.2.565. PMID 12907544.
  11. Anderson JL, Adams CD, Antman EM, et al. (August 2007). «ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine». Circulation 116 (7): e148304. DOI:10.1161/CIRCULATIONAHA.107.181940. PMID 17679616.
  12. Meine TJ, Roe MT, Chen AY, et al. (2005). «Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative». Am Heart J 149 (6): 10439. DOI:10.1016/j.ahj.2005.02.010. PMID 15976786.
  13. Routine use of oxygen in the treatment of myocardial infarction: systematic review -- Wijesinghe et al. 95 (3): 198 -- Heart.
  14. Cabello JB, Burls A, Emparanza JI, Bayliss S, Quinn T (2010). «Oxygen therapy for acute myocardial infarction». Cochrane Database Syst Rev 6 (6): CD007160. DOI:10.1002/14651858.CD007160.pub2. PMID 20556775.
  15. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr (2004). «ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction)». J Am Coll Cardiol 44 (3): 671719. DOI:10.1016/j.jacc.2004.07.002. PMID 15358045.
  16. Rossi S, editor. Australian Medicines Handbook 2006. Adelaide: Australian Medicines Handbook; 2006. ISBN 0-9757919-2-3.
  17. ISIS-2 Collaborative group (1988). «Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2». Lancet 2 (8607): 34960. PMID 2899772.
  18. Brown AL, Mann NC, Daya M, Goldberg R, Meischke H, Taylor J, Smith K, Osganian S, Cooper L. (2000). «Demographic, belief, and situational factors influencing the decision to utilize emergency medical services among chest pain patients. Rapid Early Action for Coronary Treatment (REACT) study». Circulation 102 (2): 1738. PMID 10889127.
  19. [http://www.hta.ac.uk/fullmono/mon840.pdf Main C, Palmer S, Griffin S, Jones L, Orton V, Sculpher M, et al. Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-STsegment-elevation acute coronary syndromes: a systematic review and economic evaluation. Health Technol Assess 2004;8(40).]
  20. « ».
  21. [http://www.thecochranelibrary.com/details/file/1479309/CD006536.html Clifford DM, Fisher SA, Brunskill SJ, Doree C, Mathur A, Watt S, Martin-Rendon E. Stem cell treatment for acute myocardial infarction. Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD006536. DOI: 10.1002/14651858.CD006536.pub3.]
  22. Peters RJ, Mehta SR, Fox KA, Zhao F, Lewis BS, Kopecky SL, Diaz R, Commerford PJ, Valentin V, Yusuf S; Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial Investigators. (2003). «Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study». Circulation 108 (14): 16827. DOI:10.1161/01.CIR.0000091201.39590.CB. PMID 14504182.
  23. Yusuf S, Peto R, Lewis J, Collins R, Sleight P (1985). «Beta blockade during and after myocardial infarction: an overview of the randomized trials». Prog Cardiovasc Dis 27 (5): 33571. DOI:10.1016/S0033-0620(85)80003-7. PMID 2858114.
  24. Dargie HJ. (2001). «Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial». Lancet 357 (9266): 138590. DOI:10.1016/S0140-6736(00)04560-8. PMID 11356434.
  25. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E. (1996). «The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators». N Engl J Med 335 (14): 10019. DOI:10.1056/NEJM199610033351401. PMID 8801446.
  26. Sacks FM, Moye LA, Davis BR, Cole TG, Rouleau JL, Nash DT, Pfeffer MA, Braunwald E. (1998). «Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial». Circulation 97 (15): 144652. PMID 9576424.
  27. Mozaffarian D, Micha R, Wallace S (2010). «Effects on Coronary Heart Disease of Increasing Polyunsaturated Fat in Place of Saturated Fat: A Systematic Review and Meta-Analysis of Randomized Controlled Trials». PLoS Med. 7 (3): e1000252. DOI:10.1371/journal.pmed.1000252. PMID 20351774.
  28. (2001) «Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico». Lancet 354 (9177): 44755. DOI:10.1016/S0140-6736(99)07072-5. PMID 10465168.
  29. Leaf A, Albert C, Josephson M, Steinhaus D, Kluger J, Kang J, Cox B, Zhang H, Schoenfeld D (2005). «Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake». Circulation 112 (18): 27628. DOI:10.1161/CIRCULATIONAHA.105.549527. PMID 16267249.
  30. Magee KD, Campbell SG, Moher D, Rowe BH (2008). «Heparin versus placebo for acute coronary syndromes». Cochrane Database Syst Rev (2): CD003462. DOI:10.1002/14651858.CD003462.pub2. PMID 18425889.
  31. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, et al. (1992). «Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators». N Engl J Med. 327 (10): 66977. DOI:10.1056/NEJM199209033271001. PMID 1386652.

«/w/index.php?title=__&oldid=44097113»